Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation

José Miguel Rivera-Caravaca, Gregory Y H Lip

Research output: Contribution to journal › Journal article › Research › peer-review

Keywords

@article{7a33417549184a00ab554e9eb63db06f,

title = "Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation",

keywords = "Journal Article",

author = "Rivera-Caravaca, {Jos{\'e} Miguel} and Lip, {Gregory Y H}",

year = "2017",

doi = "10.1136/ebmed-2017-110764",

language = "English",

volume = "22",

pages = "154--155",

journal = "BMJ Evidence-Based Medicine",

issn = "2515-446X",

publisher = "BMJ Group",

number = "4",

}

TY - JOUR

T1 - Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation

AU - Rivera-Caravaca, José Miguel

AU - Lip, Gregory Y H

PY - 2017

Y1 - 2017

KW - Journal Article

U2 - 10.1136/ebmed-2017-110764

DO - 10.1136/ebmed-2017-110764

M3 - Journal article

C2 - 28705921

SN - 2515-446X

VL - 22

SP - 154

EP - 155

JO - BMJ Evidence-Based Medicine

JF - BMJ Evidence-Based Medicine

IS - 4

ER -